tiprankstipranks
Advertisement
Advertisement

AGEN Stock Latest News

Agenus price target raised to $14 from $8 at B. Riley
The FlyAgenus price target raised to $14 from $8 at B. Riley
18h ago
AGEN
Agenus files to sell 2.13M shares of common stock for holders
PremiumThe Fly
Agenus files to sell 2.13M shares of common stock for holders
11d ago
AGEN
Top 3 Penny Stocks to Watch after Massive Trading Volume, 7/14/2026
PremiumMarket News
Top 3 Penny Stocks to Watch after Massive Trading Volume, 7/14/2026
17d ago
AGEN
SOBR
Why Is Agenus (AGEN) Stock Up Today?
PremiumMarket News
Why Is Agenus (AGEN) Stock Up Today?
18d ago
AGEN
Agenus price target raised to $30 from $23 at H.C. Wainwright
PremiumThe Fly
Agenus price target raised to $30 from $23 at H.C. Wainwright
18d ago
AGEN
Agenus announces strategic prioritization of neoadjuvant BOT+BAL
PremiumThe FlyAgenus announces strategic prioritization of neoadjuvant BOT+BAL
18d ago
AGEN
Agenus Secures Strategic Financing to Advance Colon Cancer Program
Premium
Company Announcements
Agenus Secures Strategic Financing to Advance Colon Cancer Program
18d ago
8K
AGEN
Agenus announces $340M private placement
Premium
The Fly
Agenus announces $340M private placement
18d ago
AGEN
LGND
Agenus Extends Debt Maturities and Warrant Expirations
PremiumCompany Announcements
Agenus Extends Debt Maturities and Warrant Expirations
24d ago
8K
AGEN
Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI
PremiumThe Fly
Agenus reports three-year Phase 1b BOT+BAL data at ESMO GI
25d ago
AGEN
Agenus announces three-year survival data from Phase 1b BOT+BAL study
PremiumThe Fly
Agenus announces three-year survival data from Phase 1b BOT+BAL study
1M ago
AGEN
Agenus Shareholders Approve Governance, Compensation and Auditors
PremiumCompany Announcements
Agenus Shareholders Approve Governance, Compensation and Auditors
1M ago
8K
AGEN
Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
PremiumCompany AnnouncementsAgenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion
2M ago
AGEN
5 Healthcare Stocks Set to Join the Russell 3000
Premium
Market News
5 Healthcare Stocks Set to Join the Russell 3000
2M ago
QSI
AGEN
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
Premium
Ratings
Reiterating Buy on AGEN as Botensilimab/Balstilimab Data Impress in Refractory Melanoma; $23 Price Target Unchanged
2M ago
AGEN
Agenus Announces Resignation of Principal Accounting Officer
PremiumCompany Announcements
Agenus Announces Resignation of Principal Accounting Officer
3M ago
8K
AGEN
Agenus announces publication of Phase 1b BOT+BAL data
PremiumThe Fly
Agenus announces publication of Phase 1b BOT+BAL data
3M ago
AGEN
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
PremiumRatings
Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained
3M ago
AGEN
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
PremiumThe Fly
Midday Fly By: Dream Finders offers to buy Beazer, Fox reports Q3 beat
3M ago
BW
GM
Agenus reports Q1 revenue $33.7M vs. $24.1M last year
PremiumThe FlyAgenus reports Q1 revenue $33.7M vs. $24.1M last year
3M ago
AGEN
Agenus provides 2026 strategic priorities
Premium
The Fly
Agenus provides 2026 strategic priorities
3M ago
AGEN
Agenus announces conclusion of SEC investigation with no enforcement action
Premium
The Fly
Agenus announces conclusion of SEC investigation with no enforcement action
3M ago
AGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >